Trends in Molecular Medicine

Papers
(The median citation count of Trends in Molecular Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Advisory Board and Contents355
Advisory Board and Contents221
Subscription and Copyright Information185
Advisory Board and Contents180
Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin159
PD-L1 at the crossroad between RNA metabolism and immunosuppression134
CXCR2 chemokine receptor – a master regulator in cancer and physiology133
Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease128
Preventing unfolded protein response-induced ion channel dysregulation to treat arrhythmias107
Targeting PERK to treat arrhythmias100
A cryptic mode of GPCR regulation revealed91
Advisory Board and Contents87
Control of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Cancer85
Subscr+copyr79
SARS-CoV-2 targets the liver and manipulates glucose metabolism77
Subscription and Copyright Information76
Advisory Board and Contents74
Advisory Board and Contents67
Advisory Board and Contents66
Advisory Board and Contents65
Stories in Molecular Medicine April 202165
Subscription and Copyright Information63
Stories in Molecular Medicine December 202162
Stories in Molecular Medicine: March 202157
Subscription and Copyright Information55
Stories in Molecular Medicine September 202155
Subscription and Copyright Information54
Resistance exercise for anxiety and depression: efficacy and plausible mechanisms53
Bridging rapid and sustained antidepressant effects of ketamine52
Autoimmune diseases and cardiovascular risk50
Neutrophils and extracellular traps in crystal-associated diseases48
TIM-3 blockade: immune and targeted therapy in DIPG47
Advisory Board and Contents46
Subscription and Copyright Information46
Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies45
Consideration of the importance of measuring thermal discomfort in biomedical research44
Advisory Board and Contents44
Advisory Board and Contents42
Polycystic kidney disease: novel insights into polycystin function41
Subscription and Copyright Information40
Subscription and Copyright Information40
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes39
Cutaneous neuroimmune crosstalk in pruritus39
Convalescent plasma to deliver therapeutic antibodies against COVID-1939
Homeostatic maintenance of the lymphatic vasculature38
Bringing vascularization into glioblastoma in vitro models38
Asthma exacerbations: the Achilles heel of asthma care35
Advisory Board and Contents35
Pre-eclampsia: Challenges for Nanomedicine Development in Pregnancy34
Unleashing cell-penetrating peptide applications for immunotherapy34
Meeting the needs of patients with ultrarare diseases34
Beneath the radar: immune-evasive cell sources for stroke therapy34
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies34
Ancestry, ethnicity, and race: explaining inequalities in cardiometabolic disease34
Post-acute anti-NMDAR encephalitis mirrors schizophrenia33
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates33
Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges33
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-233
TIM-3 inhibitors: a promising strategy for tumor immunotherapy33
Challenges and opportunities for conceiving genetically diverse sickle cell mice32
Cellular senescence in neuroinflammatory disease: new therapies for old cells?32
Subscription and Copyright Information31
Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer31
Bursts of brain erosion: seizures and age-dependent neurological vulnerability31
Translating osteoarthritis genetics research: challenging times ahead30
Microbiome-targeted interventions for the control of oral–gut dysbiosis and chronic systemic inflammation30
mRNA vaccine platforms to prevent bacterial infections30
Advisory Board and Contents28
Opportunities and challenges for biomarker discovery using electronic health record data28
Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines28
Glycosylation of blood cells during the onset and progression of atherosclerosis and myocardial infarction28
Beyond the danger signal: RNA aggregates orchestrate immunotherapy28
Influenza A Viruses: Understanding Human Host Determinants27
RyR-mediated calcium release in hippocampal health and disease27
Science around the world27
Advisory Board and Contents27
Subscription and Copyright Information26
Fc-optimized checkpoint antibodies for cancer immunotherapy25
Alternative splicing: a bridge connecting NAFLD and HCC25
Dietary interventions and precision nutrition in cancer therapy25
Vascular dysfunction in Hutchinson–Gilford progeria syndrome24
Microbiota and sleep: awakening the gut feeling24
Staging of Alzheimer’s disease: past, present, and future perspectives24
Unmasking BACE1 in aging and age-related diseases24
PROT3EcT, engineered Escherichia coli for the targeted delivery of therapeutics24
Understanding the tuberculosis granuloma: the matrix revolutions24
Imaging genomics: data fusion in uncovering disease heritability23
Vitiligo: advances in pathophysiology research and treatment development23
HPV integration and cervical cancer: a failed evolutionary viral trait23
Molecular therapy for polyQ disorders: from bench to clinical trials22
Neuroendocrine insights into neurosteroid therapy for postpartum depression22
Organoids, Where We Stand and Where We Go22
Printing New Bones: From Print-and-Implant Devices to Bioprinted Bone Organ Precursors22
COVID-19 in pregnancy: implications for fetal brain development22
The physiology of bilirubin: health and disease equilibrium21
AAV capsid design: A Goldilocks challenge21
Circular RNA translation: novel protein isoforms and clinical significance21
Hidden mysteries behind genome, epigenome, and exposome of lupus erythematosus21
Pushing the boundaries of brain organoids to study Alzheimer’s disease21
Suicide prevention in cancer: earlier is better21
Breakthroughs and bottlenecks in autophagy research21
Particulate matter and Alzheimer’s disease: an intimate connection21
The variant landscape and function of DDX3X in cancer and neurodevelopmental disorders20
d-Amino acids: new clinical pathways for brain diseases20
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies19
Advisory Board and Contents18
Harnessing the healing power of love18
Organ-specific aging in the plasma proteome predicts disease18
m6A and beyond: RNA modifications shaping angiogenesis18
Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation18
Subscription and Copyright Information18
Vaccine-based immunotherapy and related preclinical models for glioma18
Insights from HIV-1 vaccine and passive immunization efficacy trials18
Science around the world18
Fibrodysplasia ossificans progressiva emerges from obscurity17
New strategies for the treatment of chronic hepatitis B17
Oligodendrocyte pathology in Huntington’s disease: from mechanisms to therapeutics17
Targeting ACC for NASH resolution17
IBD disease-modifying therapies: insights from emerging therapeutics17
Common mechanisms in pediatric acute liver failure17
Three ‘E’ challenges for siRNA drug development16
Advisory Board and Contents16
Readthrough compounds for nonsense mutations: bridging the translational gap16
Subscription and Copyright Information16
Science around the world16
Subscr+copyr16
Subscription and Copyright Information16
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies16
Subscription and Copyright Information16
Communicating science and protecting scientists in a time of political instability16
Systemically administered alcadein peptide p3-Alcβ neutralizes brain Alzheimer’s Aβ oligomers15
Advancements in intensive eating disorder treatments: the benefit of CBT-E and integrated care models15
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation15
Senescence and tissue fibrosis: opportunities for therapeutic targeting15
Improving participant representation in the era of digital clinical studies15
Subscr+copyr15
Redefining metalloproteases specificity through network proteolysis14
Missing links in preeclampsia cell model systems of endothelial dysfunction14
Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology14
Advisory Board and Contents14
Host-informed therapies for the treatment of pneumococcal pneumonia14
Can we provide quality #MedEd on social media?14
In Utero Gene Therapy: Progress and Challenges14
How hypocretin agonists may improve the quality of wake in narcolepsy13
The Need for Research-Grade Systems Modeling Technologies for Life Science Education13
Advisory Board and Contents13
Stories in Molecular Medicine November 202113
Bioelectronic medicine potentiates endogenous NSCs for neurodegenerative diseases13
Molecular links between allergy and cancer13
Epigenetic priming in neurodevelopmental disorders13
Stories in Molecular Medicine October 202113
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects12
β2ARs: double edge sword in heart function12
Brain-specific regulatory T cell expansion limits cognitive decline12
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies12
Copy number alterations: a catastrophic orchestration of the breast cancer genome11
Circadian phase instability in bipolar disorder: a neglected essence11
Deep learning for subtyping the Alzheimer’s disease spectrum11
Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease11
Mitochondria as Therapeutic Targets in Transplantation11
Molecular mechanisms in the pathogenesis of dengue infections11
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients11
Microbes and mood: innovative biomarker approaches in depression11
Leveraging insights from cancer to improve tuberculosis therapy11
Emerging roles of cyclin-dependent kinase 7 in health and diseases10
Monoamines' role in islet cell function and type 2 diabetes risk10
Strategies to Identify Genetic Variants Causing Infertility10
Molecular pathology of rare progeroid diseases10
Unlocking the potential of agonist antibodies for treating cancer using antibody engineering10
Thymic stroma and TFII-I: towards new targeted therapies10
Post-Transcriptional Regulation in Skeletal Muscle Development, Repair, and Disease10
Hormesis as an adaptive response to infection10
Targeting monoamine oxidases in cancer: advances and opportunities10
Cancer quiescence: non-coding RNAs in the spotlight10
If it ain’t broke, break it: facilitating antigen cross-presentation10
Advisory Board and Contents10
Engineering Strategies for Allogeneic Solid Tissue Acceptance10
Telomere biology disorders: time for moving towards the clinic?10
Advisory Board and Contents9
The dual role of the TSC complex in cancer9
Trained immunity-related vaccines: innate immune memory and heterologous protection against infections9
Cell-free circulating tumor DNA profiling in cancer management9
iPSCs and DRGs: stepping stones to new pain therapies9
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?9
Amyloid and collagen templates in aortic valve calcification9
Anorexia nervosa: diagnostic, therapeutic, and risk biomarkers in clinical practice9
Dysfunctional tRNA reprogramming and codon-biased translation in cancer9
Breakthroughs and Bottlenecks in Microbiome Research9
Epigenetic regulation in intervertebral disc degeneration9
The inaccessible road to science for people with disabilities9
There is nothing as inconsistent as the OSFED diagnostic criteria9
COVID-19 vaccines in pregnancy8
Treating Niemann-Pick C lysosomal storage: approved and emerging approaches8
The gut vascular barrier: a new player in the gut–liver–brain axis8
Extracellular matrix-based cancer targeting8
Role and therapeutic implications of protein glycosylation in neuroinflammation8
Tertiary lymphoid structures in the central nervous system8
Erythropoietic protoporphyrias: updates and advances8
The molecular underpinnings of female predominance in lupus8
Data-Driven Modeling of Pregnancy-Related Complications8
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging7
Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality7
N6-methyladenosine-mediated gene regulation and therapeutic implications7
Primary cilia shape hallmarks of health and aging7
Moyamoya disease emerging as an immune-related angiopathy7
Eating disorders and obesity: bridging clinical, neurobiological, and therapeutic perspectives7
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease7
FSP1: a key regulator of ferroptosis7
Genetically modified malaria parasites as vaccine candidates6
Advisory Board and Contents6
Subscription and Copyright Information6
Deciphering the Identity of Renin Cells in Health and Disease6
Tackling ‘lost in translation’ issues: a response to Perez-Campos et al.6
Why we must fight ignorance about COVID-19 vaccines and menstrual cycles6
Advisory Board and Contents6
The spike hypothesis in vaccine-induced adverse effects: questions and answers6
Subscr+copyr6
Advisory Board and Contents6
Biomarker opportunities in the treatment of cancer-related depression6
CircRNA perspective: new strategies for RNA therapy6
Advisory Board and Contents6
Shining a light on comorbidities6
Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy6
Advisory Board and Contents6
Advisory Board and Contents6
Secondary failure: immune responses to approved protein therapeutics6
Leptin and male fertility: unraveling the molecular pathways, receptor functions, and therapeutic potential6
Amphiphysin-2 (BIN1) functions and defects in cardiac and skeletal muscle6
Dysregulation of deubiquitinylases: a linchpin of gastrointestinal diseases6
The science of storytelling: the David Attenborough style of scientific presentation5
Beyond pluripotency: Yamanaka factors drive brain growth and regeneration5
Bringing gene therapy to where it’s needed5
Environmental perception and control of gastrointestinal immunity by the enteric nervous system5
Fruitful Futures for Reproductive Health5
Advisory Board and Contents5
Unveiling the biological functions and therapeutic potentials of LONP1 in the ovary5
SOX17: escape route from immune destruction in early CRC5
Follow the CSF flow: probing multiciliated ependymal cells in brain pathology5
Fatty acid binding proteins in multiple myeloma5
Galectin-3 in metabolic disorders: mechanisms and therapeutic potential5
3-O-acylated bile acids: disrupters or harmonizers of metabolism?5
HDL and SARS CoV-2: emerging theragnostic implications5
From disparities to equity: striving for more in our treatments for feeding and eating disorders4
Enhancers in disease: molecular basis and emerging treatment strategies4
Advisory Board and Contents4
The current sociocultural background of eating disorders4
Emerging roles of MRG15 in liver metabolic diseases4
PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism4
New media facilitate adolescents’ body dissatisfaction and eating disorders in Mainland China4
TBCK syndrome: a rare multi-organ neurodegenerative disease4
0.15616607666016